BioCardia, Inc.
BCDA
$1.14
$0.043.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.55% | -10.59% | -2.75% | 18.83% | 31.33% |
| Total Depreciation and Amortization | -64.18% | -50.00% | -37.66% | -25.93% | -20.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.38% | -4.26% | -3.19% | -8.11% | -14.09% |
| Change in Net Operating Assets | 88.04% | 113.35% | -417.05% | -4,722.22% | -1,027.13% |
| Cash from Operations | 5.71% | -0.93% | -16.97% | 10.85% | 20.93% |
| Capital Expenditure | -16.67% | 60.00% | -33.33% | -200.00% | 50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.67% | 60.00% | -33.33% | -200.00% | 50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -17.60% | -26.39% | 92.38% | 65.74% | 140.47% |
| Repurchase of Common Stock | -40.71% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.72% | 41.03% | -113.61% | -105.94% | -89.12% |
| Cash from Financing | -17.38% | -25.69% | 86.41% | 58.40% | 145.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.14% | -88.47% | 84.71% | 100.00% | 120.26% |